彭博·· 11 天前AI 评分31
J&J CEO Joaquin Duato on Obesity, Cancer and AI | The David Rubenstein Show
J&J CEO Joaquin Duato on Obesity, Cancer and AI | The David Rubenstein Show
中性对 相关个股影响 轻微
强生聚焦肿瘤业务并称AI或助力药物研发
stock_ai_django 新闻打标（gpt-6-luna），方向针对资产价格，不是本站判断，也不构成投资建议
AI 导读
Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duato also talked about
来源：彭博 · bloomberg.com